Prabhakar Panzade

Prabhakar Panzade

Auto-generated profile, based on publicly available information

Prabhakar Panzade

Department of Pharmaceutics, Srinath College of Pharmacy, Aurangabad, Maharashtra, India

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 November 2022 in Nanomaterials
Verified
Journal Article
Open access
PDF file
Deepak KulkarniDeepak Kulkarni
Deepak Kulkarni
Shubham MusaleShubham Musale
Shubham Musale
PPPrabhakar Panzade
Prabhakar Panzade
Ana Cláudia Paiva-SantosAna Cláudia Paiva-Santos
Ana Cláudia Paiva-Santos
PSPratiksha Sonwane
Pratiksha Sonwane
SIMONA CAVALUSIMONA CAVALU
SIMONA CAVALU
Nanocarriers are gaining significant importance in the modern era of drug delivery. Nanofiber technology is one of the prime paradigms in nanotechnology for various biomedical and theranostic applications. Nanofibers obtained after successful electrospinning subjected to surface functionalized for drug delivery, biomedical, tissue engineering, biosensing, cell imaging and wound dressing application. Surface functionalization entirely changes physicochemical and biological properties of nanofibers. In physicochemical properties, wettability, melting point, glass transition temperature, and initial decomposition temperature significantly change offer several advantageous for nanofibers. Similarly, biological properties include cell adhesion, biocompatibility, and proliferation, also changes by functionalization of nanofibers. Various natural and synthetic materials polymers, metals, carbon materials, functional groups, proteins, and peptides, are currently used for surface modification of nanofibers. Various research studies across the globe demonstrated the usefulness of surface functionalized nanofibers in tissue engineering, wound healing, skin cancers, melanoma, and disease diagnosis. The delivery of drug through surface functionalized nanofibers results in improved permeation and bioavailability of drug which is important for better targeting of disease and therapeutic efficacy. This review provides a comprehensive insight about various techniques of surface functionalization of nanofibers along with its biomedical applications, toxicity assessment and global patent scenario.

25 September 2017 in Advanced Pharmaceutical Bulletin
Verified
Journal Article
Open access
PPPrabhakar Panzade
Prabhakar Panzade
GSGiridhar Shendarkar
Giridhar Shendarkar
SSSarfaraj Shaikh
Sarfaraj Shaikh
PRPavan Balmukund Rathi
Pavan Balmukund Rathi
Purpose: Cocrystallisation of drug with coformers is a promising approach to alter the solid sate properties of drug substances like solubility and dissolution. The objective of the present work was to prepare, formulate and evaluate the piroxicam cocrystal by screening various coformers. Methods: Cocrystals of piroxicam were prepared by dry grinding method. The melting point and solubility of crystalline phase was determined. The potential cocrystal was characterized by DSC, IR, XRPD. Other pharmaceutical properties like solubility and dissolution rate were also evaluated. Orodispersible tablets of piroxicam cocrystal were formulated, optimized and evaluated using 32 factorial design. Results: Cocrystals of piroxicam-sodium acetate revealed the variation in melting points and solubility. The cocrystals were obtained in 1:1 ratio with sodium acetate. The analysis of Infrared explicitly indicated the shifting of characteristic bands of piroxicam. The X-Ray Powder Diffraction pattern denoted the crystallinity of cocrystals and noteworthy difference in 2θ value of intense peaks. Differential scanning calorimetry spectra of cocrystals indicated altered endotherms corresponding to melting point. The pH solubility profile of piroxicam showed sigmoidal curve, which authenticated the pKa-dependent solubility. Piroxicam cocrystals also exhibited a similar pH-solubility profile. The cocrystals exhibited faster dissolution rate owing to cocrystallization as evident from 30% increase in the extent of dissolution. The orodispersible tablets of piroxicam cocrystals were successfully prepared by direct compression method using crosscarmelose sodium as superdisintegrant with improved disintegration time (30 sec) and dissolution rate.Conclusion: The piroxicam cocrystal with modified properties was prepared with sodium acetate and formulated as orodispersible tablets having faster disintegration and greater dissolution rate.

3 September 2020 in Drug Development and Industrial Pharmacy
Verified
Journal Article
Closed access
PPPrabhakar S. Panzade
Prabhakar S. Panzade
GSGiridhar R. Shendarkar
Giridhar R. Shendarkar
Pharmaceutical cocrystals are still gaining the interest of the researchers due to their potential to alter physicochemical, mechanical, and pharmacokinetic properties of active pharmaceutical ingredients without negotiating therapeutic action. The diverse new applications of cocrystals, like taste masking, reduced toxicity, patenting opportunities and commercial potential etc. acting as driving force to the rising interest of the pharmaceutical industries. Initially, cocrystals from the view of regulatory authorities, design strategies, cocrystal preparation in brief with special emphasis on scalable and solvent-free hot melt extrusion method, and practical guide to characterization has been provided. The special focus has been given to the biopharmaceutical attributes of the cocrystal. Finally, challenges before and after cocrystal preparation are presented in this review along with some commercial examples of the cocrystals.

8 April 2024 in International Journal of Polymeric Materials and Polymeric Biomaterials
Verified
Journal Article
Closed access
Deepak KulkarniDeepak Kulkarni
Deepak Kulkarni
Prabhanjan S GiramPrabhanjan S Giram
Prabhanjan S Giram
JMJayashri Mahore
Jayashri Mahore
HKHarshad S Kapare
Harshad S Kapare
PPPrabhakar Panzade
Prabhakar Panzade

3 April 2021 in Journal of Liposome Research
Verified
Journal Article
Closed access
KKKhushboo Katharotiya
Khushboo Katharotiya
GSGajanan Shinde
Gajanan Shinde
DKDhaval Katharotiya
Dhaval Katharotiya
Santosh ShelkeSantosh Shelke
Santosh Shelke
RPRakesh Patel
Rakesh Patel
PPPrabhakar Panzade
Prabhakar Panzade
The current research was undertaken to design stealth liposomes of 5-Fluorouracil for reducing its cardiotoxicity and prolong the half-life by developing long-circulating liposomes. The liposomes were prepared by the NH4EDTA gradient method, where EDTA is used as a cardioprotectant. Ascorbyl-6-palmitate was also used which helped for the synergistic effect of 5-Fluorouracil to counteract the cancer cells and provide promising application in the treatment of breast cancer cells. Taguchi design was used for screening of formulation and HSPC phospholipid was selected. The drug-excipient compatibility was checked through FTIR which showed all the excipients were compatible with the drug. The formulation was optimized by using 32 factorial design. The drug to lipid ratio (1:5) and Ascorbyl-6-Palmitate concentration (15 mg) were selected. The vesicle size of the prepared liposomes was found to be 70.12 ± 0.58 nm and uniform distribution was observed. The zeta potential and entrapment efficiency of the stealth liposomes were found −16.28 mV and 92 ± 0.007% respectively. In-vitro drug release study of formulation showed drug release of 63.50 ± 0.94% in 24 hrs. The formulation was sterilized by 0.22 µm Mixed cellulose esters (MCE) membrane filter and passed sterility test. Moreover, a biodistribution study was performed by Fluorescence microscopy and by HPLC method, which showed formulation was circulated for 24 hours. Finally, a cell line study indicated that prepared formulation possess greater anti-tumour activity. The cardiotoxicity study revealed that the stealth liposomes have minimum cardiotoxicity as compare to the plain drug.

2 November 2020 in Journal of Pharmaceutical Innovation
Verified
Journal Article
Closed access
PDF file
PPPrabhakar S. Panzade
Prabhakar S. Panzade
GSGiridhar R. Shendarkar
Giridhar R. Shendarkar
Deepak KulkarniDeepak Kulkarni
Deepak Kulkarni